Aggregatibacter actinomycetemcomitans and Atherosclerosis

A B S T R A C T

Periodontal disease is an inflammatory condition around the teeth which affects 20-50% of the worldwide population. In periodontal disease, the bacterial plaque destroys the epithelium of the periodontal pocket and breaks the barrier that separates the tissue and the circulation, allowing oral bacteria and their endotoxins and exotoxins to enter the bloodstream. This can cause health problems, such as atherosclerosis. Aggregatibacter actinomycetemcomitans (Aa) is commonly found in patients with periodontitis and the number of Aa is associated with atherosclerotic lesion size in humans. This review focuses on Aa and atherosclerosis with an emphasis on the interaction of Aa with cell types involved in atherosclerosis formation.

Keywords

Aggregatibacter, actinomycetemcomitans, atherosclerosis, periodontal disease

Introduction

Periodontal disease is an inflammatory condition around the teeth including the gum, periodontal ligament and alveolar bone. In the USA, severe periodontal disease affects about 14% - 23% of Americans and 20% to 50% of the worldwide population [1-3]. In periodontal disease, the bacterial plaque destroys the epithelium of the periodontal pocket and breaks the barrier that separates the tissue and the circulation, allowing oral bacteria and their endotoxins and exotoxins to enter the bloodstream which can cause health problems [4-6]. Indeed, oral bacteria have been detected in the carotid endarterectomy [5]. The oral bacterium Aggregatibacter actinomycetemcomitans (Aa) is found in 40-100% of patients with early-onset and aggressive forms of periodontitis, and in 30-40% of chronic periodontitis adult patients [7]. Periodontal bacterial burden and the number of Aa are associated with atherosclerosis size in humans [8, 9]. This mini review focuses on Aa and atherosclerosis with an emphasis on the interaction of Aa with cell types involved in atherosclerosis formation.

A Brief Overview of Atherosclerosis Initiation and Progression

Atherosclerosis is an inflammatory disease in which lipoproteins accumulated in the arterial wall. It accounts for 50% of deaths in developed countries [10]. Dietary lipids are packaged into large triglyceride-rich lipoproteins called chylomicrons. These are secreted into the lymph and in the blood via the thoracic duct [11]. Very low-density lipoprotein loses its triglycerides in the peripheral tissue to develop into low-density lipoprotein (LDL) and the latter can be oxidized to its oxidized form (ox-LDL) under oxidative and inflammatory conditions. LDL and ox-LDL may accumulate in the arterial intima mainly by macrophages [12, 13]. Macrophages engulf ox-LDL, but cannot utilize these lipids, and eventually transform into lipid-laden foam cells. This is the beginning of the formation of atherosclerosis [14]. Foam cells secrete inflammatory cytokines, reactive oxygen species, and other mediators [15]. In such an environment, macrophages can die, forming the ‘necrotic’ core of the mature plaque. Matrix metalloproteinases, produced by macrophages, degrade extracellular matrix macromolecules that lend to the strength of the plaque’s fibrous cap. Consequently, the fracture of a weakened fibrous cap permits blood to contact tissue factor in the plaque’s necrotic core, ultimately triggering thrombotic plaque complications including myocardial infarction, stroke, and cardiovascular death [15-17].

Aggregatibacter actinomycetemcomitans (Aa)

Aa is a non-spore-forming, non-motile hemolytic, oxidase- and catalase-positive and gram-negative anaerobic coccobacillus [18]. Aa forms small, translucent or transparent colonies with irregular edges that appear smooth, circular and convex approximately 0.5-1.0 mm in diameter [18]. Aa has different serotypes and serotypes a, b and c are dominant and comprise more than 95% of Aa [19, 20]. Aa invades and migrates through epithelial cells [21]. Aa can secrete 179 different proteins that include the endotoxin lipopolysaccharide (LPS) repeats in toxin immunostimulating factor and extracellular matrix protein adhesin A [19, 20, 22-26]. transforming growth factor-beta (TGF-β) receptor/smad2 plays an important role in the maintenance of homeostasis in the gingival epithelium [27]. Aa accelerates the expression of TGF-β receptor/smad2, which causes apoptosis of the epithelial cells, leading to the loss of the epithelial barrier [28].

The Correlation of Aa with Atherosclerosis

It has been reported that dental disease is positively correlated with an increased risk of coronary heart disease, with atherosclerosis the key underlying mechanism [7]. Poor oral hygiene, determined by the extent of dental debris and calculus, is also associated with an increased incidence of coronary heart disease [7]. For more details on the correlation between periodontal disease and atherosclerotic vascular disease, please refer to the excellent review authored by Lockhart et al. [29]. Aa can be found in atherosclerotic plaque of mice intravenously challenged with Aa, as well as in human atherosclerotic plaque [5, 30]. Using deconvolution micrographs, Aa has been detected in carotid atherosclerosis plaque regions [5]. The number of Aa is also associated with atherosclerosis size in humans [8].

In apolipoprotein E-deficient spontaneously hyperlipidemic mice, atherosclerotic plaque size is increased after treatment with Aa [30]. A range of pro-inflammatory cytokines in the serum of Aa-treated mice are increased and those cytokines include interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNFα) and monocyte chemoattractant protein-1 (MCP-1) [30]. Toll-like receptor 2, Toll-like receptor 4, intercellular adhesion molecule 1 (ICAM-1), E-selectin, P-selectin, Ox-LDL receptor-1, heat shock protein 60, chemokine ligand 19 and 21, chemokine ligand-receptor 7, and MCP-1 expression in the aorta are significantly increased in mice challenged with Aa [30].

The inflammasome related molecules interferon-inducible protein absent in melanoma 2 (AIM2), macrophage inducible Ca2+-dependent lectin receptor CLEC4E, and nucleotide-binding oligomerization domain leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) are present in the aorta [31]. AIM2 is an important component in the inflammasome complex: it can cleave the pro-inflammatory IL-1 family of cytokines into the bioactive forms of IL-1β [32]. Macrophage inducible Ca2+-dependent lectin receptor CLEC4E is a C-type lectin receptor capable of recognizing a wide range of lipid species [33]. NLRP3 inflammasome is considered a link between lipid metabolism and inflammation [34]. The roles of NLRP3 inflammasome in atherosclerosis have been reviewed by Hoseini [34]. Aa promotes the production of IL-1β and IL-18 through the stimulation of NLRP3 inflammasome [35]. Oxidative modification of LDL arises from lipid peroxidation of polyunsaturated fatty acids of phospholipids within LDL particles [36]. Lipopolysaccharide from Aa is found to LDL accumulation in RAW 264.7 macrophages, forming foam cells [37].

Interaction of Aa with Various Cell Types Involved in Atherosclerosis Formation
I Cell Types Involved in the Formation of Atherosclerosis

Various cell types are involved in the pathogenesis of atherosclerosis. Dysfunction of the endothelial cells lining the lesion-prone areas of the arterial vasculature is an important contributor to the pathobiology of atherosclerosis [38]. In lesion-prone arterial regions, the actions of pro-inflammatory factors (e.g. endotoxin) and ox-LDL lead to endothelial activation [38]. Endothelial activation induces the expression of adhesion molecules and recruitment of monocytes, T-lymphocytes, B-lymphocytes, dendritic cells and mast cells to the subendothelial space [39-41]. The activated endothelial cells and other cell types will produce pro-inflammatory cytokines and reactive oxygen species within the vessel wall. This environment promotes foam cell formation and prevents high-density lipoprotein particles from participating in cholesterol efflux and removal from foam cells [41]. Ultimately, the aging foam cells die and form a necrotic lipid core, further progressing atherosclerosis [38].

II Aa and Endothelial Cells

Aa elicits a pro-atherogenic response in endothelial cells in the form of increased leukocyte adhesion, heightened production of pro-inflammatory cytokines and chemokines, and increased pro-thrombotic properties [42-44]. Human coronary artery endothelial cells stimulated with Aa increase the production of IL-6, IL-8, ICAM-1 and platelet endothelial cell adhesion molecule [45]. Increases of IL-6 and IL-8 attract monocytes to the endothelium [46, 47]. When human coronary artery endothelial cells are challenged with Aa, the expression level of ICAM-1 or platelet endothelial cell adhesion molecule 1 is significantly enhanced, but this phenomenon is not observed when cells are exposed to heat-killed Aa [45]. Leukotoxin, an Aa-produced toxin, induces apoptosis and decreases cell viability of endothelial cells [48, 49]. Treatment with leukotoxin increased levels of both ICAM-1 and vascular cell adhesion protein 1 (106), which can result in rolling, adhesion and transmigration of monocytic cells into the vessel wall [50]. When endothelial cells are treated with Aa-derived LPS, the cytokines and chemokines (G-CSF, IL-8, RANTES, ICAM-1 and IL-6) secretion increase compared to untreated control [51, 52]. However, the concentration of TNF-α, IL-7, IL-16, TNF-R1, IL-1ra and IL-1, are higher but not significant in 3D culture compared to control. The concentrations of all those soluble factors except for platelet-derived growth factor-BB are significantly higher in 3D-Aa-LPS than in 2D Aa-LPS [52].

III Aa and Macrophages

Aa has strong cytotoxic activity against macrophage human cell line U937, resulting in apoptosis [53]. Y4 strain of Aa caused 60% apoptosis in U937 cells, and this is also observed in human monocytic cell line THP-1, via the p38 MAPK pathway [53-55]. Aa is also shown to kill monocytes in minutes to a few hours [56]. In addition, exposure of human monocytes to leukotoxin increased caspase 1 up to five folds within 10 to 20 [57].

IV Aa and T Lymphocytes

Aa can stimulate T-cells to produce higher levels of pro-inflammatory cytokine IL-22 and the transcription factor master-switch gene aryl hydrocarbon receptor (AhR), which is implicated in their differentiation [58]. T helper-17 (Th17) cells are a subset of pro-inflammatory cells and are defined by their production of IL-17, IL-17A, F, and also, I IL-21 and 22. CD4+ T cells, isolated from atherosclerosis coronary blood vessels, express IL-17 [59]. In addition, circulating IL-17 is shown to be associated with the progression and severity of carotid artery plaques [60]. Aa infected ApoE-deficient mice have been shown to increase significantly in splenic IL-17+ and Th17 related serum cytokines (IL-1β, IL-6, IL-17 and TGF-β), as well as Th17related gene expression (IL-1β, IL-6, IL-17 Receptor A, IL-21, TGF-β, and STAT 3) [31, 61, 62].

Aa infected mice also increase 3 times the relative expression of Th17 related microRNA (miR-155 and miR146b) in mouse and human atherosclerosis [63]. Mir-155 has been shown to promote the development of inflammatory Th17/Th1 cell subsets [63, 64]. Mir-146b is involved in the pathogenesis of murine viral myocarditis by regulating Th17 differentiation [60].

V Aa and Dendritic Cells

Aa can stimulate dendritic cells to produce higher levels of pro-inflammatory cytokine IL-6 and TNF-a [58]. Actinomyces spp. promote activation of dendritic cells on human monocyte dendritic cell lines by induction of CD40, CD83 and CD86 [65]. CD40 ligand and CD70 activation have been shown to be of significance in an Aa rat model of periodontal disease-mediated bone reabsorption [66]. Aa has also been proven to increase CD14+ monocytes that promote increased Th17 and IL-17 immune responses in periodontal diseases [67]. Aa serotype b has an increased ability to produce Th1 and Th17 cytokine production in dendritic cells [68]. Th1 and Th17 promote both cell-mediated immunity and inflammatory response, respectively. In the presence of Aa subtype b, higher levels of IL-1β, IL-6, IL-12, IL-23, IFN-γ and TNFα are released in comparison to other serotypes [68, 69]. Dendritic cells stimulated with serotype b Aa have an increased TLR2 dependent cytokine transcription activation pathway [69]. Th-17 cytokine production increases in Aa Apolipoprotein E-deficient mouse models, suggesting a link between Aa, dendritic cell produced Th-17 and an increase in atherosclerotic plaque production [31].

VI Aa and Mast Cells

The mast cell is a leukocyte that is a granulocyte derived from the hematopoietic stem cell, which serves to respond to pathogens and modulate innate and adaptive immune responses [70]. Aa induced the secretion of TNF-α and MCP-1 in mast cells [71, 72].

Conclusion

Oral bacterium Aa plays an important role in atherosclerosis formation and progression in people with periodontitis. Aa and its endotoxins and exotoxins can interact with endothelial cells to produce adhesion molecules, leading to inflammatory cell recruitment into the subendothelial space. Aa and its endotoxins can also promote foam cell formation and release of pro-inflammatory cytokines, which then facilitate the initiation and progression of atherosclerosis (Figure 1).

Science Repository

Figure 1: Aa induced atherosclerosis and cardiovascular events. Aa and its endotoxins and exotoxin exotoxins enter the circulation via breaks of the dental epithelium. They activate endothelial cells (ECs) and lead to the recruitment of inflammatory cells. Macrophage will engulf LDL and ox-LDL leading to foam cell formation. The inflammatory environment in the subendothelial space will cause apoptosis of foam cells and lead to the formation of lipid core. In addition, inflammatory cells will produce matrix metalloproteinases (MMPs) which will weaken and break the fibrotic cap. Consequently, contact of blood with tissue factor in the lipid core will lead to thrombosis and cardiovascular (CV) events such as myocardial infarction and stroke. Aa: Aggregatibacter actinomycetemcomitans; LDL: Low-Density Lipoprotein; ox-LDL: oxidized Low-Density Lipoprotein; ROS: Reactive Oxygen Species.

Enlarge Image

Abbreviations

Aa: Aggregatibacter actinomycetemcomitans
ICAM-1: Intercellular Adhesion Molecule 1
IL: Interleukin
LDL: Low-Density Lipoprotein
LPS: Lipopolysaccharide
MCP-1: Monocyte Chemoattractant Protein-1
NLRP3: Nucleotide-Binding Oligomerization Domain Leucine-Rich Repeat and Pyrin Domain-Containing Protein 3
ox-LDL: oxidized LDL
Th17: T helper-17
TNFα: Tumor Necrosis Factor-Alpha
TGF-β: Transforming Growth Factor-Beta

Article Info

Article Type
Review Article
Publication history
Received: Mon 23, Nov 2020
Accepted: Fri 04, Dec 2020
Published: Thu 24, Dec 2020
Copyright
© 2023 Yutang Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JICOA.2020.06.06

Author Info

Dinh Tam Nguyen Jack Anesi Michelle Steicke Yutang Wang

Corresponding Author
Yutang Wang
Discipline of Life Sciences, School of Science, Psychology and Sport, Federation University Australia, Ballarat, Victoria, Australia

Figures & Tables

Science Repository

Figure 1: Aa induced atherosclerosis and cardiovascular events. Aa and its endotoxins and exotoxin exotoxins enter the circulation via breaks of the dental epithelium. They activate endothelial cells (ECs) and lead to the recruitment of inflammatory cells. Macrophage will engulf LDL and ox-LDL leading to foam cell formation. The inflammatory environment in the subendothelial space will cause apoptosis of foam cells and lead to the formation of lipid core. In addition, inflammatory cells will produce matrix metalloproteinases (MMPs) which will weaken and break the fibrotic cap. Consequently, contact of blood with tissue factor in the lipid core will lead to thrombosis and cardiovascular (CV) events such as myocardial infarction and stroke. Aa: Aggregatibacter actinomycetemcomitans; LDL: Low-Density Lipoprotein; ox-LDL: oxidized Low-Density Lipoprotein; ROS: Reactive Oxygen Species.



References

  1. Serio FG, Siegel MA, Slade BE (1991) Plasma cell gingivitis of unusual origin. A case report. J Periodontol 62: 390-393. [Crossref]
  2. Boehm TK, Scannapieco FA (2007) The epidemiology, consequences and management of periodontal disease in older adults. J Am Dent Assoc 138: 26S-33S. [Crossref]
  3. Sanz M, D'Aiuto F, Deanfield J, Fernandez Avilés F (2010) European workshop in periodontal health and cardiovascular disease—scientific evidence on the association between periodontal and cardiovascular diseases: a review of the literature. Eur Heart J Suppl 12: B3-B12.
  4. Beck JD, Offenbacher S (2001) The Association Between Periodontal Diseases and Cardiovascular Diseases: A State-of-the-Science Review. Ann Periodontol 6: 9-15. [Crossref]
  5. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske Fox A (2005) Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 25: e17-e18. [Crossref]
  6. Chhibber Goel J, Singhal V, Bhowmik D, Vivek R, Parakh N et al. (2016) Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes 2: 7. [Crossref]
  7. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM (1993) Dental disease and risk of coronary heart disease and mortality. BMJ 306: 688-691. [Crossref]
  8. Desvarieux M, Demmer RT, Rundek T, Boden Albala B, Jacobs DR Jr et al. (2005) Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111: 576-582. [Crossref]
  9. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R et al. (2006) Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Internal Med 166: 554-559. [Crossref]
  10. Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32: 2045-2051. [Crossref]
  11. Redgrave TG (2008) Chylomicrons in disease-future challenges: Invited keynote address. Atheroscler Suppl 9: 3-6. [Crossref]
  12. Glass CK, Witztum JL (2001) Atherosclerosis. the road ahead. Cell 104: 503-516. [Crossref]
  13. Heinecke JW (2006) Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander? J Exp Med 203: 813-816. [Crossref]
  14. Angelovich TA, Hearps AC, Jaworowski A (2015) Inflammation-induced foam cell formation in chronic inflammatory disease. Immunol Cell Biol 93: 683-693. [Crossref]
  15. Geovanini GR, Libby P (2018) Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond) 132: 1243-1252. [Crossref]
  16. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874. [Crossref]
  17. Libby P, Ridker PM, Hansson GK (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54: 2129-2138. [Crossref]
  18. Fives Taylor PM, Meyer DH, Mintz KP, Brissette C (1999) Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 20: 136-167. [Crossref]
  19. Welch RA (1991) Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol 5: 521-528. [Crossref]
  20. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Ann Rev Biochem 71: 635-700. [Crossref]
  21. Fives Taylor PM, Meyer DH, Mintz KP, Brissette C (1999) Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 20: 136-167. [Crossref]
  22. Benz R, Schmid A, Wagner W, Goebel W (1989) Pore formation by the Escherichia coli hemolysin: evidence for an association-dissociation equilibrium of the pore-forming aggregates. Infect Immun 57: 887-895. [Crossref]
  23. Jeong SJ, Yee ST, Jo WS, Yu SH, Lee SH et al. (2000) A novel factor isolated from Actinobacillus actinomycetemcomitans stimulates mouse B cells and human peripheral blood mononuclear cells. Infect Immun 68: 5132-5138. [Crossref]
  24. Jo WS, Yee ST, Yoon S, Nam BH, Do E et al. (2006) Immunostimulating factor isolated from actinobacillus actinomycetemcomitans stimulates monocytes and inflammatory macrophages. Microbiol Immunol 50: 535-542. [Crossref]
  25. Mintz KP (2004) Identification of an extracellular matrix protein adhesin, EmaA, which mediates the adhesion of Actinobacillus actinomycetemcomitans to collagen. Microbiology (Reading) 150: 2677-2688. [Crossref]
  26. Tang G, Ruiz T, Barrantes Reynolds R, Mintz KP (2007) Molecular heterogeneity of EmaA, an oligomeric autotransporter adhesin of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Microbiology (Reading) 153: 2447-2457. [Crossref]
  27. Ohgushi M, Kuroki S, Fukamachi H, O'Reilly LA, Kuida K et al. (2005) Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells. Mol Cell Biol 25: 10017-10028. [Crossref]
  28. Yoshimoto T, Fujita T, Ouhara K, Kajiya M, Imai H et al. (2014) Smad2 is involved in Aggregatibacter actinomycetemcomitans-induced apoptosis. J Dent Res 93: 1148-1154. [Crossref]
  29. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M et al. (2012) Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? a scientific statement from the American Heart Association. Circulation 125: 2520-2544. [Crossref]
  30. Zhang T, Kurita Ochiai T, Hashizume T, Du Y, Oguchi S et al. (2010) Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol 59: 143-151. [Crossref]
  31. Jia R, Hashizume Takizawa T, Du Y, Yamamoto M, Kurita Ochiai T (2015) Aggregatibacter actinomycetemcomitans induces Th17 cells in atherosclerotic lesions. Pathog Dis 73: ftu027. [Crossref]
  32. Schroder K, Tschopp J (2010) The inflammasomes. Cell 140: 821-832. [Crossref]
  33. Williams SJ (2017) Sensing Lipids with Mincle: Structure and Function. Front Immunol 8: 1662. [Crossref]
  34. Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A et al. (2018) NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J Cell Physiol 233: 2116-2132. [Crossref]
  35. Belibasakis GN, Johansson A (2012) Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 59: 124-130. [Crossref]
  36. Horkko S, Binder CJ, Shaw PX, Chang MK, Silverman G et al. (2000) Immunological responses to oxidized LDL. Free Radic Biol Med 28: 1771-1779. [Crossref]
  37. Morishita M, Ariyoshi W, Okinaga T, Usui M, Nakashima K et al. (2013) A. actinomycetemcomitans LPS enhances foam cell formation induced by LDL. J Dent Res 92: 241-246. [Crossref]
  38. Gimbrone MA Jr, García Cardeña G (2016) Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res 118: 620-636. [Crossref]
  39. Gil Pulido J, Zernecke A (2017) Antigen-presenting dendritic cells in atherosclerosis. Eur J Pharmacol 816: 25-31. [Crossref]
  40. Herrero Fernandez B, Gomez Bris R, Somovilla Crespo B, Gonzalez Granado JM (2019) Immunobiology of Atherosclerosis: A Complex Net of Interactions. Int J Mol Sci 20: 5293. [Crossref]
  41. Kovanen PT (2019) Mast Cells as Potential Accelerators of Human Atherosclerosis-From Early to Late Lesions. Int J Mol Sci 20: 4479. [Crossref]
  42. Schenkein HA, Barbour SE, Berry CR, Kipps B, Tew JG (2000) Invasion of human vascular endothelial cells by Actinobacillus actinomycetemcomitans via the receptor for platelet-activating factor. Infect Immun 68: 5416-5419. [Crossref]
  43. Kang IC, Kuramitsu HK (2002) Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol 34: 311-317. [Crossref]
  44. Henderson B, Nair SP, Ward JM, Wilson M (2003) Molecular Pathogenicity of the Oral Opportunistic Pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57: 29-55. [Crossref]
  45. Gualtero DF, Viafara Garcia SM, Morantes SJ, Buitrago DM, Gonzalez OA et al. (2017) Rosuvastatin Inhibits Interleukin (IL)-8 and IL-6 Production in Human Coronary Artery Endothelial Cells Stimulated With Aggregatibacter actinomycetemcomitans Serotype b. J Periodontol 88: 225-235. [Crossref]
  46. Gerszten RE, Garcia Zepeda EA, Lim YC, Yoshida M, Ding HA et al. (1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723. [Crossref]
  47. Jin J, Samuvel DJ, Zhang X, Li Y, Lu Z et al. (2011) Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells. Mol Immunol 49: 423-432. [Crossref]
  48. Ohguchi M, Ishisaki A, Okahashi N, Koide M, Koseki T et al. (1998) Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis. Infect Immun 66: 5980-5987. [Crossref]
  49. Dietmann A, Millonig A, Combes V, Couraud PO, Kachlany SC et al. (2013) Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells. Microb Pathog 61-62: 43-50. [Crossref]
  50. Hebert MJ, Gullans SR, Mackenzie HS, Brady HR (1998) Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: evidence for an interleukin-1beta-dependent paracrine loop. Am J Pathol 152: 523-532. [Crossref]
  51. Alekseeva T, Unger RE, Brochhausen C, Brown RA, Kirkpatrick JC (2014) Engineering a microvascular capillary bed in a tissue-like collagen construct. Tissue Eng Part A 20: 2656-2665. [Crossref]
  52. Gualtero DF, Lafaurie GI, Fontanilla MR (2019) Differential responses of endothelial cells on three-dimensional scaffolds to lipopolysaccharides from periodontopathogens. Mol Oral Microbiol 34: 183-193. [Crossref]
  53. Fukunaga M, Tsuruda K (2001) Actinobacillus actinomycetemcomitans induces lethal effects on the macrophage-like human cell line U937. Oral Microbiol Immunol 16: 284-289. [Crossref]
  54. Nonaka K, Ishisaki A, Okahashi N, Koseki T, Kato S et al. (2001) Involvement of caspases in apoptotic cell death of murine macrophages infected with Actinobacillus actinomycetemcomitans. J Periodontal Res 36: 40-47. [Crossref]
  55. Kato S, Sugimura N, Nakashima K, Nishihara T, Kowashi Y (2005) Actinobacillus actinomycetemcomitans induces apoptosis in human monocytic THP-1 cells. J Med Microbiol 54: 293-298. [Crossref]
  56. Taichman NS, Dean RT, Sanderson CJ (1980) Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 28: 258-268. [Crossref]
  57. Kelk P, Johansson A, Claesson R, Hanstrom L, Kalfas S (2003) Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 71: 4448-4455. [Crossref]
  58. Diaz Zuniga J, Melgar Rodriguez S, Monasterio G, Pujol M, Rojas L et al. (2017) Differential human Th22-lymphocyte response triggered by Aggregatibacter actinomycetemcomitans serotypes. Arch Oral Biol 78: 26-33. [Crossref]
  59. Eid RE, Rao DA, Zhou J, Lo SL, Ranjbaran H et al. (2009) Interleukin-17 and Interferon-gamma Are Produced Concomitantly by Human Coronary Artery-sInfiltrating T Cells and Act Synergistically on Vascular Smooth Muscle Cells. Circulation 119: 1424-1432. [Crossref]
  60. Liu Z, Lu F, Pan H, Zhao Y, Wang S et al. (2012) Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication. Atherosclerosis 221: 232-241. [Crossref]
  61. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28: 454-467. [Crossref]
  62. Kim S, Park MH, Song YR, Na HS, Chung J (2016) Aggregatibacter actinomycetemcomitans-Induced AIM2 Inflammasome Activation Is Suppressed by Xylitol in Differentiated THP-1 Macrophages. J Periodontol 87: e116-e126. [Crossref]
  63. Tanabe SI, Grenier D (2008) Macrophage tolerance response to Aggregatibacter actinomycetemcomitans lipopolysaccharide induces differential regulation of tumor necrosis factor-α, interleukin-1β and matrix metalloproteinase 9 secretion. J Periodont Res 43: 372-377. [Crossref]
  64. Zhang J, Cheng Y, Cui W, Li M, Li B et al. (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266: 56-63. [Crossref]
  65. Larsen JM, Steen Jensen DB, Laursen JM, Søndergaard JN, Musavian HS et al. (2012) Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PloS One 7: e31976. [Crossref]
  66. Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H et al. (2010) Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol 25: 275-92. [Crossref]
  67. Cheng WC, van Asten SD, Burns LA, Evans HG, Walter GJ et al. (2016) Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol 46: 2211-2221. [Crossref]
  68. Díaz Zúñiga J, Yáñez JP, Alvarez C, Melgar Rodríguez S, Hernández M et al. (2014) Serotype-dependent response of human dendritic cells stimulated with Aggregatibacter actinomycetemcomitans. J Clin Periodontol 41: 242-251. [Crossref]
  69. Díaz Zúñiga J, Monasterio G, Alvarez C, Melgar Rodríguez S, Beníte A et al. (2015) Variability of the dendritic cell response triggered by different serotypes of Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis is toll-like receptor 2 (TLR2) or TLR4 dependent. J Periodontol 86: 108-119. [Crossref]
  70. Urb M, Sheppard DC (2012) The role of mast cells in the defence against pathogens. PLoS Pathog 8: e1002619. [Crossref]
  71. Oksaharju A, Lappalainen J, Tuomainen AM, Pussinen PJ, Puolakkainen M et al. (2009) Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J Cell Molecul Med 13: 103-113. [Crossref]
  72. Lima HG, Pinke KH, Gardizani TP, Souza Júnior DA, Carlos D et al. (2013) Mast cells act as phagocytes against the periodontopathogen Aggregatibacter actinomycetemcomitans. J Periodontol 84: 265-272. [Crossref]